Pharma & Bio
Lifestyle
NextBio’s ‘Nexpire F’ Demonstrates Potential for Endless Evolution... Proven by a Series of Clinical Successes
#NextBioMedical is reshaping the medical device market landscape, centered on its knee osteoarthritis treatment, NexSphere F. This is because NexSphere F, which started as a treatment for knee osteoar…
Lifestyle
Dasan Pharmaceutical Accelerates CDMO Push in Japan... "Full-Scale Supply of Flagship Pellet Product Begins"
Dasan Pharmaceutical has successfully completed an on-site inspection by Japan’s Pharmaceutical and Medical Devices Agency (PMDA), accelerating its efforts to penetrate the local market and expand its…
Lifestyle
Vivozon Pharma and Lunit Rally on Commercialization and Nvidia Tailwinds [K-Bio Pulse]
Following a broad rally across Korea’s pharmaceutical and biotech sector the previous day, trading on June 10 shifted toward stock-specific momentum. Vivozon Pharm surged nearly 10% on expectations fo…
Lifestyle
Bibozon Pharma and Lunit Rise in Tandem... Expectations for Commercialization and NVIDIA-Driven Expansion [Bio Spotlight]
Following a broad rally across the pharmaceutical and biotech sectors the previous day, the market on the 10th saw a differentiated trend centered on stocks with individual momentum. Vibozon Pharmaceu…
Technology
Countdown to the '270 Trillion Won Patent Cliff'… K-Bio Targets Big Pharma’s Territory Through Speed and Niche Markets
The largest-ever patent cliff is looming over the global pharmaceutical and biotech markets. This is because the expiration dates for the exclusive rights to global mega-blockbuster drugs—which previo…
Lifestyle
The Era of 2 Million Foreign Patients: "They Start by Looking for Shrink in Korea"... Why You Should Keep an Eye on Classis
With the dawn of an era featuring 2 million foreign patients, #Classis’ growth strategy and global scalability are drawing renewed attention. This is because a virtuous cycle is forming where medical …
Technology
“Animal testing alone is not enough”… HLB BioStep Expands Next-Generation Preclinical Platform
As interest grows in next-generation preclinical evaluation technologies that can replace animal testing in the global pharmaceutical industry, the business model of #HLB BioStep, a contract research …
Technology
Pharos Soars on Nvidia Link, Daewon Tops KOSPI [K-Bio Pulse]
South Korean pharmaceutical and biotech stocks staged a rare broad-based rally on Aug. 5 as investor sentiment lifted shares across multiple sectors.As Nvidia CEO Jensen Huang’s visit to South Korea f…
Technology
“From Jensen Huang-themed stocks to new obesity drugs”… CoreLine, Daewon, and Pharos on the rise [Bio Spotlight]
On the 5th, domestic pharmaceutical and biotech stocks showed a rare simultaneous surge. As investor sentiment flocked to artificial intelligence (AI)-related stocks following the visit to South Korea…
Lifestyle
“Send in a stool sample and AI will recommend supplements”… CJ Basa Sets Sights on the GLP-1 Era
“We are no longer in an era where people can just take any probiotic. An era is coming where AI analyzes a customer’s gut microbiome and recommends the most suitable nutrients.”As the global healthcar…